Exai Bio Appoints Karen E. Knudsen to Board of Directors
Exai Bio, a leading RNA- and AI-based liquid biopsy company, has announced the appointment of Karen E. Knudsen, MBA, PhD, to its board of directors. Knudsen, the former CEO of…
Category News
Read MoreExai Bio Appoints Karen E. Knudsen to Board of Directors
OnMed to Debut at CES 2025, Revolutionizing Healthcare Access for Underserved Communities
OnMed, a leading tech-enabled hybrid care company, is set to debut its innovative OnMed CareStation at CES 2025 in Las Vegas, Nevada. This breakthrough solution is transforming how underserved communities…
Veterans’ Research Foundation Highlights CyPath® Lung’s Addition to Federal Supply Schedule
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive tests for early-stage cancer detection, will join Federal Supply System (FSS) officials today in a joint presentation. The…
Almirall Launches The Hive, a New Innovation Hub for Life Sciences
Almirall, a global pharmaceutical company focused on medical dermatology, today unveiled “The Hive,” a groundbreaking scientific research hub located at its R&D center in Barcelona, Spain. The Hive is designed…
Henry Schein Unveils New Technology at Greater New York Dental Meeting
Henry Schein, Inc. (Nasdaq: HSIC) is showcasing a comprehensive range of dental solutions at the 2024 Greater New York Dental Meeting (GNYDM), taking place at the Henry Schein Dental (#4215)…
Honoring Employee Giving and Volunteerism
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live…
UnitedHealth Group Updates Outlook Before Investor Conference
UnitedHealth Group (NYSE: UNH) has announced its financial guidance in advance of its annual Investor Conference, which will take place on December 4, starting at 8:00 a.m. ET. The company…
Accellix Platform Chosen by American Red Cross for Cell Therapy Material Characterization
The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform…
Janux Selects Doses for Phase 1b Trials of JANX007 in mCRPC Following Positive Phase 1a Results
Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will…
Bayer Highlights Expanding Radiology Portfolio at RSNA 2024
Bayer continues to enhance its comprehensive radiology portfolio by advancing innovations in Artificial Intelligence (AI) and expanding its product pipeline. These advancements will be showcased at the 2024 Radiological Society…
Sickday Medical House Calls: Top Provider of On-Demand Care for NYC Travelers
Sickday Medical House Calls, the largest and longest-serving medical house call practice in New York City, is reshaping the way travelers experience healthcare. For nearly two decades, Sickday has been…
Teladoc Health Launches AI Motion Detection for Hospital Bed Safety
Teladoc Health has introduced a groundbreaking technology that combines artificial intelligence (AI) and real-time monitoring to enhance patient safety in hospitals. This innovative solution, known as Virtual Sitter, is designed…